Current concepts and novel applications of LH activity in ovarian stimulation (Q35188679)

7 August 2017

1 reference

title

Current concepts and novel applications of LH activity in ovarian stimulation (English)

1 reference

7 August 2017

Marco Filicori

1

1 reference

7 August 2017

Graciela E Cognigni

2

1 reference

7 August 2017

Patrizia Pocognoli

3

1 reference

7 August 2017

Walter Ciampaglia

4

1 reference

7 August 2017

Silvia Bernardi

5

1 reference

7 August 2017

publication date

1 August 2003

1 reference

Trends in Endocrinology and Metabolism

7 August 2017

published in

1 reference

7 August 2017

volume

14

1 reference

7 August 2017

issue

6

1 reference

7 August 2017

page(s)

267-273

1 reference

The Role of Gonadotropins in the Selection of the Preovulatory Follicle

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Follicular oestrogen synthesis: the 'two-cell, two-gonadotrophin' model revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Stimulation and growth of antral ovarian follicles by selective LH activity administration in women

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Intracytoplasmic sperm injection pregnancy after low-dose human chorionic gonadotropin alone to support ovarian folliculogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Examination of the relative role of FSH and LH in the mechanism of ovulatory follicle selection in sheep

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Human chorionic gonadotrophin contributes to the bioactivity of Pergonal

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Effects of metformin on early pregnancy loss in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Corticosteroids for treating Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Meta-analysis of recombinant versus urinary-derived FSH: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

1 reference

7 January 2021

Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Blastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programs

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Use of luteinizing hormone in the treatment of infertility: time for reassessment?

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating hormone compared to human menopausal gonadotrophin

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Intracytoplasmic sperm injection after follicle stimulation with highly purified human follicle-stimulating hormone compared with human menopausal gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Follicular fluid markers of oocyte developmental potential

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Relationship between circulating human chorionic gonadotropin levels and premature luteinization in cycles of controlled ovarian hyperstimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

In premature luteinization, progesterone induces secretory transformation of the endometrium without impairment of embryo viability

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a "long protocol" of gonadotropin releasing hormone analogue and human menopausal gonadotropins

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Premature luteinization is not eliminated by pituitary desensitization with leuprolide acetate in women undergoing gonadotrophin stimulation who demonstrated premature luteinization in a prior gonadotrophin-only cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

Clinical review 126: Roles and novel regimens of luteinizing hormone and follicle-stimulating hormone in ovulation induction

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2803%2900085-7

7 January 2021

10.1016/S1043-2760(03)00085-7

Identifiers

DOI

1 reference

7 August 2017

1 reference